safety of glp 1 and Tolerability Glucagon-Like Peptide-1 Receptor Agonists: A State-of-the-Art Narrative Review | Drugs Long-Term GLP-1 Safety: GI Risks
Description
Only 44% gained weight
Unlike FDA-approved medications such as Mounjaro and Wegovy, which demonstrate significant weight loss of 15-25% in clinical testing, commercial GLP-1 patches lack scientific validation for effective transdermal delivery of appetite-regulating compounds
Many patients benefit from structured treatment cycles rather than viewing GLP-1 as one-time only
Frequently Asked Questions Glossary of Terms References What Is Retatrutide and How Does It Work
